Justia Products Liability Opinion Summaries

Steven Watts, an automotive repair shop owner, was diagnosed with mesothelioma in 2019, a disease linked to asbestos exposure. He and his wife, Cindy Watts, filed a lawsuit against 28 defendants, later adding eight more. By the time of trial, only one defendant, Pneumo Abex, LLC (Abex), remained. The jury awarded the plaintiffs $2,943,653 in economic damages, $6.75 million in noneconomic damages, and $1 million for loss of consortium, attributing 60% fault to Abex, 25% to other brake manufacturers, and 15% to Watts.The trial court had granted a directed verdict against Abex on its sophisticated user defense, which argued that Watts, as a trained mechanic and business owner, should have known about the dangers of asbestos. The court also made several rulings affecting the allocation of fault, including refusing to include joint compound manufacturers on the verdict form and precluding Abex from using Watts’s interrogatory responses.The California Court of Appeal, First Appellate District, Division Two, reviewed the case. The court found that the trial court erred in directing the verdict against Abex on the sophisticated user defense, as there was substantial evidence that Watts should have known about the asbestos risks. The court also found errors in the trial court’s rulings on the allocation of fault, including the exclusion of joint compound manufacturers from the verdict form and the preclusion of Watts’s interrogatory responses.The appellate court reversed the trial court’s judgment and remanded the case for a new trial, allowing Abex to present its sophisticated user defense and addressing the allocation of fault issues. The court also upheld the trial court’s discretion in allocating pretrial settlements but found that the overall handling of the case warranted a new trial. View "Watts v. Pneumo Abex" on Justia Law

This case involves a lawsuit filed by Cornelius Williams against J-M Manufacturing Company, Inc. (JMM), a supplier of asbestos-cement pipe. Williams alleged that he developed mesothelioma due to secondary exposure to asbestos from his brother Nathan's work with asbestos-cement pipe over a period of more than 20 years. Williams and Nathan did not live together, but had regular close contact during Nathan's employment. The jury found JMM liable under theories of design defect and failure to warn, concluding that the pipe sold by JMM was a substantial factor in increasing Williams' risk of developing cancer. JMM appealed the decision.The trial court dismissed Williams' negligence claim, but not the strict liability claim. The jury found in favor of Williams on his remaining strict liability claim, awarding him significant damages. JMM moved for judgment notwithstanding the verdict (JNOV) and, in the alternative, for a new trial, arguing that the trial court erred in its interpretation and application of a previous case, Kesner v. Superior Court, to preclude only the negligence cause of action. The motion was denied. JMM also appealed from the judgment and order denying its motion for JNOV.The Court of Appeal of the State of California First Appellate District Division Two affirmed the lower court's decision. The appellate court rejected JMM's arguments that (1) judgment must be entered in its favor because, under Kesner, strict liability does not apply to Williams; (2) the judgment must be reversed for lack of substantial evidence; or (3) a new trial is necessary because the trial court abused its discretion on certain evidentiary rulings. View "Williams v. J-M Manufacturing Company" on Justia Law

Five diabetic patients, Henry J. Hebert, Traci Moore, Aliya Campbell Pierre, Tiffanie Tsakiris, and Brenda Bottiglier, were prescribed the Dexcom G6 Continuous Glucose Monitoring System (Dexcom G6) to manage their diabetes. The device allegedly malfunctioned, failing to alert them of dangerous glucose levels, resulting in serious injuries and, in Hebert's case, death. The patients and Hebert's daughters filed separate product liability actions against Dexcom, Inc., the manufacturer. Dexcom moved to compel arbitration, arguing that each patient had agreed to arbitrate disputes when they installed the G6 App on their devices and clicked "I agree to Terms of Use."The trial court granted Dexcom's motions to compel arbitration in all five cases. The plaintiffs petitioned the appellate court for a writ of mandate directing the trial court to vacate its orders compelling them to arbitrate. The appellate court consolidated the cases and issued an order directing Dexcom to show cause why the relief sought should not be granted.The appellate court concluded that the trial court erred. Although a clickwrap agreement, where an internet user accepts a website’s terms of use by clicking an “I agree” or “I accept” button, is generally enforceable, Dexcom’s G6 App clickwrap agreement was not. The court found that Dexcom undid whatever notice it might have provided of the contractual terms by explicitly telling the user that clicking the box constituted authorization for Dexcom to collect and store the user’s sensitive, personal health information. For this reason, Dexcom could not meet its burden of demonstrating that the same click constituted unambiguous acceptance of the Terms of Use, including the arbitration provision. Consequently, arbitration agreements were not formed with any of the plaintiffs. The court granted the petitions and directed the trial court to vacate its orders granting Dexcom’s motions to compel arbitration and to enter new orders denying the motions. View "Herzog v. Superior Court" on Justia Law

In the case before the Court of Appeal of the State of California First Appellate District Division Four, the plaintiffs, thousands of individuals who suffered adverse effects from the use of a prescription drug, TDF, made by Gilead Life Sciences, Inc., brought a claim of negligence and fraudulent concealment against Gilead. The plaintiffs alleged that while Gilead was developing TDF, it discovered a similar, but chemically distinct and safer potential drug, TAF. However, Gilead allegedly decided to defer development of TAF because it was concerned that the immediate development of TAF would reduce its financial return from TDF. Gilead sought summary judgment on the ground that in order to recover for harm caused by a manufactured product, the plaintiff must prove that the product was defective. The trial court denied Gilead's motion for summary judgment in its entirety.In reviewing this case, the appellate court held that the trial court was correct to deny Gilead's motion for summary judgment on the negligence claim. The court reasoned that a manufacturer's duty of reasonable care can extend beyond the duty not to market a defective product. The court found that the factual basis of the plaintiffs' claim was that Gilead knew TAF was safer than TDF, but decided to defer development of TAF to maximize its profits. The court held that if Gilead's decision to postpone development of TAF indeed breached its duty of reasonable care to users of TDF, then Gilead could potentially be held liable.However, the appellate court reversed the trial court's decision regarding plaintiffs' claim for fraudulent concealment. The court concluded that Gilead's duty to plaintiffs did not extend to the disclosure of information about TAF, as it was not available as an alternative treatment for HIV/AIDS at the time the alleged concealment occurred. Consequently, the court granted in part and denied in part Gilead's petition for a writ of mandate, directing the superior court to vacate its order denying Gilead's motion for summary judgment and to enter a new order denying summary adjudication of the negligence claim but granting summary adjudication of the fraudulent concealment claim. View "Gilead Tenofovir Cases" on Justia Law

In this case, Crista Miller tripped on a vertical misalignment of less than one inch between a metal plate covering an underground utility vault, owned by the Pacific Gas and Electric Company (PG&E), and the surrounding sidewalk adjacent to a property owned by Hip Sen Benevolent Association (Hip Sen), resulting in an injury to her ankle. Miller filed a lawsuit against both PG&E and Hip Sen, alleging general negligence and premises liability. The trial court granted summary judgment in favor of the defendants, ruling that the lawsuit was barred by the trivial defect doctrine.Miller appealed, but the Court of Appeal of the State of California, First Appellate District, Division Three, affirmed the trial court's ruling. The appellate court concluded that the vertical misalignment was a trivial defect as a matter of law. The court stated that to recover damages for negligence or premises liability, Miller had to prove that the defendants breached a legal duty to either repair or warn about the existence of the misalignment. However, it is well-established law that landowners are not liable for damages caused by minor, trivial, or insignificant defects in property. Even considering the steepness of the sidewalk, the weather conditions, the time of the incident, and the crowded nature of the street, the court found that these factors did not render the misalignment a dangerous condition. The court also found that the city's guidelines and repair notices did not impose a legal duty to repair such minor defects.Miller also argued that the city's repair notices to PG&E and Hip Sen for their violations of the city's Guidelines rendered them liable under a theory of negligence per se. However, the appellate court found this argument to be forfeited as Miller did not raise this issue in the trial court and only presented it for the first time in her appellate reply brief.Therefore, the appellate court concluded that no reasonable trier of fact could find the trivial sidewalk defect posed a substantial risk of injury to a foreseeable pedestrian exercising due care and affirmed the trial court's grant of summary judgment in favor of the defendants. View "Miller v. Pacific Gas & Electric Co." on Justia Law

Appellants’ father died in a multi-car accident caused by a deer crossing State Route 154 (SR-154). Appellants sued respondent California Department of Transportation (Caltrans) and others for negligence. They alleged the road constituted a dangerous condition under Government Code section 835. The trial court found that design immunity applied to Caltrans and granted summary judgment. Appellants contend the trial court erred when it found design immunity was a complete defense to Caltrans’ liability. They also contend the court failed to address a separate basis of liability, failed to warn when it ruled on the motion for summary judgment.The Second Appellate District affirmed. Appellants’ theory of the case, in sum, is that Caltrans designed SR-154 without certain specific features they contend would have made the highway safer. The court explained that Caltrans need not produce additional evidence to prove this point. A traffic engineer attested to the applicable design standards and how Caltrans addressed the dangers posed by deer entering traffic and vehicles crossing the median. This constitutes substantial evidence of advance approval. The court wrote that it would not second-guess the decision of Caltrans to include or omit certain design features. The court concluded that substantial evidence showed that a reasonable public employee would have adopted the SR-154 design plans, even without the features and changes Appellants contend Caltrans should have considered and included. View "Stufkosky v. Department of Transportation" on Justia Law

Mark Kielar challenged a superior court’s decision to grant Hyundai Motor America’s (Hyundai) motion to compel arbitration of his causes of action for violation of the Song-Beverly Consumer Warranty Act, and fraudulent inducement arising from alleged mechanical defects in the condition of his 2012 Hyundai Tucson. The superior court’s ruling followed Court of Appeal's earlier decision in Felisilda v. FCA US LLC, 53 Cal.App.5th 486 (2020) and concluded Hyundai, a nonsignatory manufacturer, could enforce the arbitration provision in the sales contract between Kielar and his local car dealership under the doctrine of equitable estoppel. The Court of Appeal joined recent decisions that have disagreed with Felisilda and concluded the court erred in ordering arbitration. Therefore, it issued a preemptory writ of mandate compelling the superior court to vacate its June 16, 2022 order and enter a new order denying Hyundai’s motion. View "Kielar v. Super. Ct." on Justia Law

Raul Camacho was installing glass panels when he fell out of a scissor lift manufactured by JLG Industries Inc. (JLG). Camacho failed to latch a chain that was designed to guard the lift’s entrance. Camacho sued JLG for strict products liability, failure to warn, and related claims. At a jury trial, Camacho alleged the scissor lift as designed with the chain invited human error, and the foreseeable risk of harm could have been avoided if JLG had marketed only its alternative design with a self-closing gate. Camacho also alleged there was a defective warning label on the lift. At the close of evidence, JLG moved for a directed verdict. The trial court granted the motion. The court ruled in order to show causation Camacho needed to prove if the chain been latched, “the accident would have happened anyway.” To this, the Court of Appeal disagreed: "Camacho only needed to make a prima facie showing that the alternative design with the self-closing gate would have prevented his fall. Under a risk-benefit test, it was then JLG’s burden to prove the benefits of the chain outweighed its risks." The Court found Camacho made a prima facie showing of causation, and the jury could have reasonably inferred that had a self-closing gate been in place, Camacho’s fall would have been prevented. The Court also found the jurors could have reasonably inferred JLG’s allegedly defective warning label was also a substantial factor in causing Camacho’s injuries. Thus, the Court reversed the judgment and directed the trial court to vacate its order granting JLG’s motion for a directed verdict. View "Camacho v. JLG Industries" on Justia Law

This appeal involved the effect of an antiwaiver provision of the Song-Beverly Consumer Warranty Act on a release executed as part of a pre-litigation settlement between plaintiff-appellant Derek Rheinhart and defendants-respondents Nissan North America, Inc. and Mossy Nissan, Inc. (collectively Nissan) over issues that had arisen with Rheinhart’s leased Nissan vehicle. After Rheinhart entered into the settlement agreement and release, he filed a lawsuit alleging violations of the Act and seeking repurchase of his vehicle as well as other statutory remedies. Nissan moved for summary judgment on grounds the settlement agreement and release, which Rheinhart admitted he read and had an opportunity to review before signing, extinguished his claims. The trial court granted the motion, finding section 1790.1 of the Act applied to waivers of consumer warranties in connection with a product purchase, not to releases negotiated to end disputes about those warranties, and thus rejected Rheinhart’s argument that the settlement was unenforceable. Rheinhart contends the court erred. He argued the settlement agreement and release violated section 1790.1 and was unenforceable as a matter of law. The Court of Appeal reversed, finding the settlement agreement and release contravened Rheinhart’s substantive rights under the Act and was void and unenforceable as against public policy. View "Rheinhart v. Nissan North America" on Justia Law

Plaintiff Kamiya Perry appealed a judgment entered in favor of defendant Kia Motors America, Inc. (Kia) after a jury found in favor of Kia in her automobile defect trial. On appeal, she argued: (1) the trial court abused its discretion by refusing to instruct the jury that Kia had concealed evidence (certain engineering documents) during discovery; (2) the trial court erred by excluding the testimony of Kia’s paralegal who verified discovery requests relevant to the engineering documents; and (3) she was not given a fair trial because the jurors were required to deliberate in a small room, which, in the midst of the coronavirus disease 2019 (COVID-19) pandemic, incentivized the jury to complete their deliberations quickly. Finding no reversible error, the Court of Appeal affirmed the trial court's judgment. View "Perry v. Kia Motors America, Inc." on Justia Law